Table 2.
Dyslipidemia by comorbidity with hypertension, diabetes, and medical profiles of patients (n = 372).
| Variable | Frequency (%) | TC ≥ 240 mg/dL (6.21 mmol/) | TG ≥ 200 mg/dL (2.26 mmol/) | LDL-C ≥ 160 mg/dL (4.14 mmol/) | HDL-C < 40 mg/dL (1.03 mmol/L) | |
|---|---|---|---|---|---|---|
| Classifications of Hypertensive patients | Normal | 69(18.5) | 4(5.8) | 3(4.3) | 2(2.9) | 5(7.2) |
| Stage 1 | 77(20.7) | 9(11,7) | 18(23.4) | 7(9.1) | 25(32.5) | |
| Stage 2 | 127(34.1) | 35(27.6) | 41(32.3) | 25(19.7) | 49(38.6) | |
| Stage 3 | 99(26.6) | 25(25.3) | 29(29.3) | 26(26.3) | 36(36.4) | |
| Total | 372 | 73(19.6) | 91(24.5) | 60(16.1) | 115(30.9) | |
| Duration of hypertension | <5 | 84(22.6) | 10(11.9) | 16(19.0) | 8(9.5) | 21(25) |
| 5–9 | 73(19.6) | 11(15.1) | 15(20.5) | 11(15.1) | 18(24.7) | |
| 10–14 | 56(15.1) | 6(10.7) | 12(21.4) | 6(10.7) | 17(30.4) | |
| 15–20 | 68(18.3) | 16(23.5) | 18(26.5) | 20(29.4) | 29(42.6) | |
| >20 | 91(24.5) | 30(32.9) | 30(32.9) | 15(27.5) | 30(32.9) | |
| Total | 372 | 73(19.6) | 91(24.5) | 60(16.1) | 115(30.9) | |
| Diabetes mellitus | Yes | 87(23.4) | 39(44.8) | 41(47.1) | 29(33.3) | 42(48.3) |
| No | 285(76.6) | 34(11.9) | 50(17.5) | 31(10.9) | 73(25.6) | |
| Total | 372 | 73(19.6) | 91(24.5) | 60(16.1) | 115(30.9) | |
| BMI | Underweight | 36(9.7) | 2(5.6) | 4(11.1) | 2(5.6) | 5(13.9) |
| Normal | 122(32.8) | 8(6.6) | 11(9.0) | 6(4.9) | 18(14.8) | |
| Overweight | 121(32.5) | 27(22.3) | 34(28.1) | 22(18.2) | 39(32.2) | |
| Obesity | 93(25.0) | 36(38.7) | 42(45.2) | 30(32.3) | 53(56.9) | |
| Total | 372 | 73(19.6) | 91(24.5) | 60(16.1) | 115(30.9) | |
| Family history of lipid | Yes | 102(27.4) | 30(29.4) | 55(53.9) | 38(37.3) | 52(50.9) |
| No | 270(72.6) | 43(15.9) | 36(13.3) | 22(8.1) | 63(23.3) | |
| Total | 372 | 73(19.6) | 91(24.5) | 60(16.1) | 115(30.9) | |
| Overall prevalence of Dyslipidemia | Yes | 180(48.4) | ||||
| No | 192(51.6) | |||||